Clinical Trials on 乳腺癌,男性 in United Kingdom
总计27248个结果
-
Jonsson Comprehensive Cancer Center完全的HER2阳性乳腺癌 | 男性乳腺癌 | IV 期乳腺癌 | 复发性乳腺癌 | 中枢神经系统转移美国
-
National Cancer Institute (NCI)完全的
-
European Organisation for Research and Treatment...Hellenic Oncology Research Group; Latin American Cooperative Oncology Group; Hellenic Cooperative... 和其他合作者主动,不招人
-
Icahn School of Medicine at Mount SinaiNew York University; National Institute on Deafness and Other Communication Disorders (NIDCD); Ohio University 和其他合作者招聘中
-
ConcrRoyal Marsden NHS Foundation Trust; Institute of Cancer Research, United Kingdom; Durham University邀请报名
-
Imperial College LondonMedical Research Council; ECMC招聘中
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)完全的神经毒性 | 周围神经病变 | 男性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌美国
-
University of WashingtonNational Cancer Institute (NCI)完全的IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性 | HER2/Neu 阴性 | 男性乳腺癌美国
-
Icahn School of Medicine at Mount SinaiNational Institute on Deafness and Other Communication Disorders (NIDCD)完全的
-
H. Lee Moffitt Cancer Center and Research Institute终止乳腺癌 | 乳腺癌,男性 | HER2阳性乳腺癌 | HER-2基因扩增 | 乳腺癌女性 | HER2阳性乳腺癌 | HER-2 蛋白过表达美国
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis完全的
-
National Cancer Institute (NCI)终止复发性乳腺癌 | IIIA期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 男性乳腺癌美国
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; National Institute for Health Research, United...邀请报名
-
University of OxfordPublic Health England; Cancer Research UK主动,不招人
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Breakthrough Breast Cancer未知
-
University of the West of EnglandNational Institute for Health Research, United Kingdom尚未招聘
-
Institute of Cancer Research, United Kingdom终止
-
Guy's and St Thomas' NHS Foundation TrustKing's College London未知
-
University College, LondonNational Institute for Health Research, United Kingdom完全的
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of Defense主动,不招人
-
H. Lee Moffitt Cancer Center and Research Institute撤销
-
Ourotech, Inc.Barts & The London NHS Trust; Imperial College Healthcare NHS Trust; Hampshire Hospitals NHS Foundation... 和其他合作者招聘中
-
Queen Mary University of LondonHoffmann-La Roche; MedSIR; Westdeutsche Studiengruppe GmbH (WSG)主动,不招人
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的男性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 乳腺导管原位癌 | 小叶性乳腺癌原位癌美国
-
Queen Mary University of LondonHoffmann-La Roche; Asan Medical Center; Kliniken Essen-Mitte; MedSIR主动,不招人
-
Norfolk and Norwich University Hospitals NHS Foundation...完全的
-
University of East AngliaQuadram Institute Bioscience; Clinical Research and Trials Unit (Norfolk & Norwich University... 和其他合作者完全的
-
Royal Marsden NHS Foundation Trust完全的
-
National Cancer Institute (NCI)完全的HER2阳性乳腺癌 | 男性乳腺癌 | IV 期乳腺癌 | 复发性乳腺癌 | 中枢神经系统转移 | 脑转移瘤美国
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; Brighton and Sussex University Hospitals NHS Trust招聘中
-
Ourotech, Inc.Barts & The London NHS Trust招聘中
-
National Cancer Institute (NCI)终止HER2阳性乳腺癌 | 男性乳腺癌 | IV 期乳腺癌 | IIIC期乳腺癌 | 胃食管连接部腺癌 | 复发性乳腺癌 | IV 期胃癌 | 复发性胃癌 | 复发性食道癌 | IV 期食管癌 | IIIC期胃癌 | IIIC 期食管癌美国
-
Novartis Pharmaceuticals完全的
-
University of WashingtonNational Cancer Institute (NCI)完全的男性乳腺癌 | IV 期乳腺癌 | 三阴性乳腺癌 | 复发性乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌 | HER2 阴性乳腺癌 | 遗传性乳腺癌/卵巢癌 - BRCA1 | 遗传性乳腺癌/卵巢癌 - BRCA2美国
-
National Cancer Institute (NCI)完全的IV 期乳腺癌 | 复发性乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性 | 孕激素受体阳性 | 男性乳腺癌美国
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer Now招聘中转移性乳腺癌 | 三阴性乳腺癌 | HER2阳性乳腺癌 | 局部晚期乳腺癌 | 复发性乳腺癌 | ER+乳腺癌英国
-
National Health Service, United KingdomSouthern Health and Social Care Trust完全的
-
Providence Health & ServicesBrooklyn ImmunoTherapeutics, LLC主动,不招人
-
University of ManchesterManchester University NHS Foundation Trust完全的
-
Imperial College LondonCancer Research UK完全的
-
Region Örebro CountyUniversity of Patras; Siemens Corporation, Corporate Technology; Fundacio Clinic Barcelona; UBITECH 和其他合作者主动,不招人
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia; Hospital... 和其他合作者完全的